Contact this trialFirst, we need to learn more about you.
Pharmacotherapy
Insulin Therapy for Gestational Diabetes
Recruiting3 awardsPhase 4
Milwaukee, Wisconsin
This trial is comparing two different thresholds for when to start medical treatment for gestational diabetes mellitus (GDM). Pregnant women with GDM will be randomly assigned to start treatment when they reach at least 20% or 40% above the target goal for capillary blood glucose (CBG) levels. The investigators think that a lower threshold of 20% will lead to fewer obstetric and medical complications.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service